Dr. Gabriela Mabel Espinoza, MD

Dr. Espinoza practices at SSM Health Saint Louis University Hospital in Saint Louis, Missouri, part of SSM Health Care.

Dr. Espinoza's NPI, 1518983741, was assigned on July 14, 2006. Dr. Espinoza graduated from Louisiana State University School of Medicine in New Orleans in 2000. Dr. Espinoza holds Missouri license 2004006986.

Dr. Espinoza's primary practice is SSM Health Saint Louis University Hospital, at 1201 S Grand Blvd, Saint Louis, MO 63104 in St. Louis City. The practice phone is (314) 257-8000.

Dr. Espinoza's primary practice is SSM Health Saint Louis University Hospital in Saint Louis, Missouri, part of SSM Health Care. The medical group on file is SLUCare Physician Group. Dmand AI also links Dr. Espinoza to 1 more behavioral health center and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Espinoza practices, 3 sites in all. Vendor and product names are available with a free account.

Ophthalmology is Dr. Espinoza's primary specialty in the NPI Registry, under taxonomy code 207W00000X. Dr. Espinoza is licensed in Missouri.

CMS data shows 183 Medicare services from Dr. Espinoza across 7 procedure codes in 2024, for 131 Medicare patients. Medicare paid $19,340 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 131 Medicare patients who saw Dr. Espinoza in 2024. The largest group is 65 to 74, with 69 patients. 75% of them have high cholesterol, and 73% have high blood pressure. 13% are also on Medicaid. Their average risk score is 1.40, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Espinoza's median patient age at 66, with 66% women.

In 2024, Dr. Espinoza wrote 186 Medicare Part D claims for 61 patients. 90% of them were for generic drugs. CMS names the drug for 75 of them, across 4 drugs with 11 or more claims each, at $1,011 in total drug cost. In 2023, CMS named 96 claims across 5 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 85 out of 100 for Dr. Espinoza for performance year 2024, reported as part of a group. Dr. Espinoza accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Melanoma (skin cancer) excision: 1 to 10 procedures (CMS shows small counts as a range)

Removal or shaving of skin growth: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 12 papers to Dr. Espinoza, published from 2016 to 2023. 2019 was the busiest year, with 2. The most frequent topics are Diagnosis, Differential, Eye Diseases and Vasculitis. Dr. Espinoza has published most often in Curr Rheumatol Rep. Dr. Espinoza's most frequent co-authors are Levent Akduman, MD, Georgios Alexopoulos, MD and John Jing-Wei Chen, MD, PhD.

CMS Open Payments shows 79 general payments to Dr. Espinoza from 12 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 80% of the total. Bausch & Lomb Americas Inc. paid the most, $500.

Dr. Espinoza graduated from Louisiana State University School of Medicine in New Orleans in 2000.